Large-scale testing (Phase 3)Study completedNCT00949039
What this trial is testing
Study Comparing Isolated Pelvic Perfusion With TNF-α 0.3 mg and Melphalan 1.5 mg/kg Versus Standard Treatment in Patients With Non Resectable, Recurrent Gynaecologic or Digestive Pelvic Cancer
Who this might be right for
Gynaecologic or Digestive Pelvic Cancer
Gustave Roussy, Cancer Campus, Grand Paris 101